Sign in

emmajb001.bsky.social

@emmajb001.bsky.social
5 followers 10 following 1 posts
PostsRepliesMedia
Reposted by @emmajb001.bsky.social
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 10/11/2025
@caldaslab.bsky.social rocks! @ims-mrl.bsky.social @hebrewuniversity.bsky.social @lautenbergc.bsky.social The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes: Cell Reports Medicine www.cell.com/cell-reports...
cell.com
The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes
Tu et al. present a systematic analysis of the tumor microenvironment across 14,837 breast cancers, identifying distinct cellular patterns that predict disease-specific survival independently of genom...
085
Reposted by @emmajb001.bsky.social
Oscar M Rueda @ruedalab.bsky.social · 22/04/2025
How much data and resolution do we need to estimate homologous recombination deficiency in breast cancer? Rong Zhu answers this question in our latest paper: febs.onlinelibrary.wiley.com/doi/full/10....
febs.onlinelibrary.wiley.com
FEBS Press
This study develops a semi-supervised classifier integrating multi-genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer....
063
Reposted by @emmajb001.bsky.social
Oscar M Rueda @ruedalab.bsky.social · 16/04/2025
Excited to share our latest work on monitoring response to treatment using ctDNA and shallow WGS using a Bayesian Model developed by Solon Karapanagiotis with @Carloscaldas1960.bsky.social, Emma Beddowes and @mortegaduran.bsky.social febs.onlinelibrary.wiley.com/doi/full/10....
0128
Reposted by @emmajb001.bsky.social
21 Group @21group.bsky.social · 20/01/2025
New blog posting A story of precarity at a Russell Group University There were 25 people employed on the grants; 3 senior research associates, 10 research associates, 6 research assistants & 6 grad students This is what happened to us 21percent.org?p=1371
1105
Reposted by @emmajb001.bsky.social
Padmanee (Pam) Sharma, MD, PhD @pamsharmamdphd.bsky.social · 25/11/2024
www.nature.com/articles/s41... Sharing our latest review article to highlight the importance of appropriately developing combination strategies for immune checkpoint therapy. Grateful for working with 3 brilliant scientists: Sangeeta Goswami, Kristen Pauken & Linghua Wang
nature.com
Next-generation combination approaches for immune checkpoint therapy - Nature Immunology
In this Review, Sharma and colleagues describe the current landscape of combination therapies and discuss requirements for the development of effective combination strategies.
17827